Molecular genetics of uveal melanoma.
- 1 January 2003
- journal article
- review article
- Published by Taylor & Francis in Current Eye Research
- Vol. 27 (2) , 69-74
- https://doi.org/10.1076/ceyr.27.2.69.15952
Abstract
In the past decade, there have been impressive advances in our understanding of chromosomal, genetic and molecular alterations that occur in uveal melanoma. Nevertheless, a coherent picture of the molecular pathogenesis of this eye cancer is yet to emerge. Herein, we review the findings to date, discuss the insights they provide, and suggest future directions for molecular research in uveal melanoma.Keywords
This publication has 23 references indexed in Scilit:
- Contribution of Germline Mutations inBRCA2,P16INK4A,P14ARFandP15to Uveal MelanomaInvestigative Opthalmology & Visual Science, 2003
- New perspectives for tumor pathology provided by comparative genomic hybridizationInternational Journal of Clinical Oncology, 2002
- Altered expression of rb and p53 in uveal melanomas following plaque radiotherapyAmerican Journal of Ophthalmology, 2002
- c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanomaBritish Journal of Ophthalmology, 1999
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Cancer Cell CyclesScience, 1996
- Constitutional alterations in p16 in patients with uveal melanomaMelanoma Research, 1996
- Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16)Ophthalmic Genetics, 1996
- Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanomaMelanoma Research, 1993
- Loss of chromosome 3 alleles and multiplication of chromosome 8 alleles in uveal melanomaGenes, Chromosomes and Cancer, 1992